trial · primary record
ONC-PluReceptor NK cells
Recurrent B-Cell Non-Hodgkin Lymphoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2033-09-30 |
| Primary endpoint | Safety and Adverse Events (AEs) |
| Registry ID | NCT07283679 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:41.720Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07283679
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.